Two Sigma Securities’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,673
Closed -$247K 3357
2023
Q4
$247K Buy
+3,673
New +$256K ﹤0.01% 2188
2023
Q1
Sell
-3,114
Closed -$345K 3029
2022
Q4
$359K Buy
3,114
+391
+14% +$45.5K 0.01% 1370
2022
Q3
$295K Buy
+2,723
New +$390K 0.01% 1586
2022
Q2
Sell
-1,332
Closed -$238K 2603
2022
Q1
$227K Buy
+1,332
New +$251K 0.01% 1645

Other funds holding MED

Two Sigma Securities's MED Position: Q1 2024 in Review

Two Sigma Securities sold out of Medifast (MED) in Q1 2024, closing a stake of 3,673 shares — an estimated $247K sold.

Two Sigma Securities first reported a position in MED in Q1 2022 and held it in 4 quarters. The position peaked at $359K in Q4 2022. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Two Sigma Securities reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 3,673 Medifast shares in Q1 2024, an estimated $247K.
  • Two Sigma Securities first reported a position in Medifast in Q1 2022 and held it in 4 quarters.
  • Two Sigma Securities's Medifast position peaked at $359K in Q4 2022.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.